Surgical Automations, a Dallas-based surgical-robotics company operating in stealth mode, has closed an oversubscribed $3.4 million seed round to accelerate development of its next-generation gastrointestinal (GI) endoscopy platform. The funding round was co-led by Dr. Fred Moll, founder of Intuitive Surgical, and TurboStart, a Bengaluru-based cross-border venture capital firm.
The financing will help the company advance its flagship product, the Vāsuki Robotic System, toward pre-clinical validation and initial human studies. The platform integrates robotics, advanced sensing, and AI-driven automated navigation to simplify complex endoscopic procedures and enhance precision. By automating key steps of GI procedures, such as colonoscopies, the company aims to make screening safer, faster, and easier for both clinicians and patients.
Surgical Automations’ mission is to transform gastrointestinal endoscopy through automation and artificial intelligence, providing gastroenterologists with improved visualization and control during diagnostic and interventional procedures.
The company’s seed round also included participation from several physicians and members of community organizations, including the Rajput Association of North America (RANA), the Indian Institute of Technology (IIT) Alumni Association of North Texas, and the Maharana Association of North America.
Founded in North Texas, Surgical Automations is developing technology that combines global deep-tech innovation with local medical expertise. The company remains in stealth as it continues to refine its robotic system for clinical use.
KEY QUOTES:
“Surgical robotics is entering a new era where automation and intelligence are poised to transform clinical care. Surgical Automations is pursuing one of the most important opportunities in endoscopy, combining bold innovation with the pragmatism needed to bring meaningful change to patient care.”
Dr. Fred Moll, Co-lead Investor and Founder of Intuitive Surgical
“Colorectal cancer is the second leading cause of cancer deaths, yet the screening experience remains painful, inconsistent, and underserved by technology. We backed Surgical Automations because they’re re-imagining this from first principles with the right blend of AI, robotics, and regulatory clarity. This team’s deep domain insight aligns with our thesis of backing global deep-tech for human health.”
Ganesh Raju, Founder of TurboStart
“Surgical Automations exemplifies the kind of global, deep-technology innovation that advances human health while being headquartered in North Texas.”
Dr. Srinivas ‘Benne’ Bette, Founder of the IIT Entrepreneur Advisor Network
